Vetoquinol SA Logo

Vetoquinol SA

Develops and markets veterinary medicines for companion animals and livestock.

VETO | PA

Overview

Corporate Details

ISIN(s):
FR0004186856
LEI:
969500YP0AETQIK48R39
Country:
France
Address:
Village, 70200 MAGNY-VERNOIS

Description

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-10-30 17:45
Quarterly financial reporting / Third quarter financial report
English PDF 723.0 KB
2024-10-30 17:45
Information financière trimestrielle / Information financière du troisième trim…
French PDF 728.1 KB
2024-10-04 08:45
FORMULAIRE DE DECLARATION D'ACTIONS ET DROITS DE VOTE
French PDF 366.0 KB
2024-09-12 17:45
Inside Information / News release on accounts, results
English PDF 219.4 KB
2024-09-12 17:45
Informations privilégiées / Communiqué sur comptes, résultats
French PDF 221.9 KB
2024-09-12 17:45
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French PDF 173.2 KB
2024-09-04 12:00
FORMULAIRE DE DECLARATION D'ACTIONS ET DROITS DE VOTE
French PDF 32.3 KB
2024-08-05 20:00
REPORTING SUR LE CAPITAL ET LES DROITS DE VOTE JUILLET 2024
French PDF 277.5 KB
2024-05-06 10:40
FORMULAIRE DE DECLARATION D'ACTIONS ET DROITS DE VOTE
French PDF 369.5 KB
2024-05-06 09:15
FORMULAIRE DE DECLARATION D'ACTIONS ET DROITS DE VOTE
French PDF 34.0 KB
2024-04-29 17:45
Quarterly financial reporting / First quarter financial report
English PDF 185.9 KB
2024-04-29 17:45
Information financière trimestrielle / Information financière du premier trimes…
French PDF 187.6 KB
2024-04-24 14:51
Annual financial and audit reports / Terms of availability of the annual financ…
English PDF 536.0 KB
2024-04-24 14:51
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French PDF 537.6 KB
2024-04-24 14:50
Rapports financiers et d'audit annuels / Rapport financier annuel
French ZIP 22.3 MB

Automate Your Workflow. Get a real-time feed of all Vetoquinol SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vetoquinol SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vetoquinol SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-25 N/A Other Sell 4,000 399,600.00 EUR
2024-07-25 N/A Other Buy 4,000 399,600.00 EUR
2024-03-21 N/A Other Sell 3,500 346,500.00 EUR
2024-03-21 N/A Other Buy 3,500 346,500.00 EUR
2024-01-03 N/A Other Buy 1,800 182,880.00 EUR
2023-11-16 N/A Other Buy 1,000 87,500.00 EUR
2023-11-13 N/A Other Sell 1,000 87,500.00 EUR
2023-09-08 N/A Other Buy 400 33,960.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.